Switzerland buys Pfizer’s COVID-19 antiviral Paxlovid

BERLIN (Financial Eye) – Switzerland signed a contract to buy Pfizer (NYSE:)’s anti-viral drug Paxlovid to treat Covid-19, it said on Friday.

The European country said it had signed a contract to buy 12,000 packages and first treatments for certain at-risk patients would start this month.